Literature DB >> 2036032

T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.

H Miyauchi1, H Hosokawa, T Akaeda, H Iba, Y Asada.   

Abstract

A patient with bromisovalum-induced toxic epidermal necrolysis showed pronounced delayed hypersensitivity to bromisovalum by patch testing. Biopsy specimens from the cutaneous lesion and the site of the positive patch test reaction were analyzed and compared immunohistologically. The findings were similar: most of the mononuclear cells disposed along the dermoepidermal junction and migrating into the epidermis were CD8-positive lymphocytes, whereas the dermal inflammatory infiltrates were composed predominantly of CD4-positive lymphocytes. This case showed the potential usefulness of patch testing in evaluating cases of toxic epidermal necrolysis. We believe that delayed hypersensitivity plays a crucial role in the development of drug-induced toxic epidermal necrolysis. Furthermore, potential effector cells with phenotypic characteristics of CD8-positive lymphocytes (suppressor/cytotoxic T cells) seem to represent important mediators of the epidermal damage of the cutaneous lesion in our case.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036032

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

3.  Early pathological features of the cornea in toxic epidermal necrolysis.

Authors:  G P Williams; H S Mudhar; M Leyland
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

Review 4.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.

Authors:  Sanjoy Roychowdhury; Craig K Svensson
Journal:  AAPS J       Date:  2005-12-09       Impact factor: 4.009

5.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

6.  Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.

Authors:  L Le Cleach; S Delaire; L Boumsell; M Bagot; I Bourgault-Villada; A Bensussan; J C Roujeau
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report.

Authors:  Sarit Cohen; Allan Billig; Dean Ad-El
Journal:  J Med Case Rep       Date:  2009-12-10

8.  Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study.

Authors:  F Lebargy; P Wolkenstein; M Gisselbrecht; F Lange; J Fleury-Feith; C Delclaux; E Roupie; J Revuz; J C Roujeau
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

9.  Diverse expression of TNF-α and CCL27 in serum and blister of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Fang Wang; Yanting Ye; Ze-Yu Luo; Qian Gao; Di-Qing Luo; Xingqi Zhang
Journal:  Clin Transl Allergy       Date:  2018-04-20       Impact factor: 5.871

Review 10.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.